Abeona Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.589; its P/E ratio is -1.32; Abeona Therapeutics is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	$ 3.50M	-	$ 68.00K
Gross Profit	-	-	$ 3.50M	-	$ 209.00K
EBIT	$ -16.48M	$ -11.73M	$ -18.68M	$ 15.07M	$ -950.00K
EBITDA	$ -15.99M	$ -10.77M	$ -17.80M	$ 15.84M	$ -1.65M
Net Income Common Stockholders	$ -16.64M	$ -11.80M	$ -16.65M	$ 14.97M	$ -1.04M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 52.23M	$ 53.75M	$ 36.77M	$ 40.36M	$ 52.15M
Total Assets	$ 64.00M	$ 66.09M	$ 53.55M	$ 53.34M	$ 64.21M
Total Debt	$ 9.98M	$ 5.69M	$ 5.97M	$ 7.32M	$ 7.63M
Net Debt	$ -42.25M	$ -48.06M	$ -30.80M	$ -33.05M	$ -44.52M
Total Liabilities	$ 49.18M	$ 44.05M	$ 44.20M	$ 34.60M	$ 37.45M
Stockholders Equity	$ 14.83M	$ 22.04M	$ 9.35M	$ 18.74M	$ 26.76M
Cash Flow	-
Free Cash Flow	$ -9.26M	$ -5.78M	$ -10.14M	$ -11.96M	$ -13.88M
Operating Cash Flow	$ -9.23M	$ -5.75M	$ -10.28M	$ -11.74M	$ -14.00M
Investing Cash Flow	$ 11.53M	$ -18.74M	$ 5.21M	$ 2.21M	$ -25.29M
Financing Cash Flow	$ 7.47M	$ 22.98M	$ 6.62M	$ -4.00K	$ 42.77M

Currency in USD

Abeona Therapeutics Earnings and Revenue History

Income Statement >

Abeona Therapeutics Debt to Assets

Balance Sheet >

Abeona Therapeutics Cash Flow

Cash Flow >

Abeona Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing